Extracorporeal management of valproic acid toxicity: A case report and review of the literature

Ziyad Al Aly, Praveen Yalamanchili, Esther Gonzalez

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations


The incidence of intentional or accidental valproic acid (VPA) overdose is increasing. Severe VPA toxicity may lead to coma and death. Traditionally the treatment of patients with VPA toxicity has been limited to supportive measures. VPA is highly protein bound and therefore it is considered not to be removable by extracorporeal means. However, studies of VPA toxicokinetics indicate that at blood levels that exceed therapeutic concentrations, VPA protein binding sites become saturated, leading to increased concentration of the free unbound drug. The free unbound drug has a small molecular weight and therefore it is theoretically amenable to removal by extracorporeal means. We present a patient with VPA toxicity who was successfully treated with "in-series" hemodialysis and hemoperfu-sion followed by continuous venovenous hemodiafiltration (CVVHDF) and review the literature on the management of VPA toxicity using extracorporeal therapies.

Original languageEnglish
Pages (from-to)62-66
Number of pages5
JournalSeminars in Dialysis
Issue number1
StatePublished - 2005


Dive into the research topics of 'Extracorporeal management of valproic acid toxicity: A case report and review of the literature'. Together they form a unique fingerprint.

Cite this